Frontlight ResearchEarly access
Kidney cancer trials in India
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
- Where
- Ahmedabad, Bangalore, Bhubaneswar, Chandigarh, Chhatrapati Sambhajinagar, Hyderabad, Kolhāpur, Kolkata, Mysore, Nagpur, Nashik, Navi Mumbai, New Delhi, Puducherry, Pune, Rohtak, Surat, Thane, Vijayawada, Visakhapatnam
- Age
- 18 years and over
- People
- 50
- Run by
- Aurigene Discovery Technologies Limited
See details and how to joinNCT05865002